C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Director – Health Economics and Outcomes Research - Health Economics and Outcomes Research

Biology & BiotechPosted on Nov 4
Full-timeRemote in USA$192k - $250k

About the Job

Requirements

  • Proficiency in advanced statistical and modeling techniques for economic evaluation, including Markov models, decision trees, and cohort simulations.
  • In-depth knowledge of United States and global healthcare systems, global health technology assessment requirements, and clinical development to identify evidence gaps and formulate evidence-generation and communication strategies.
  • Ability to generate peer-reviewed publications communicating study findings in scientific channels in alignment with product publication and overall health economics and outcomes research evidence-generation strategies.
  • Expertise preparing and delivering high-quality, evidence-based health economic reports and presentations to internal teams, health technology assessment bodies, and payers.
  • Ability to manage multiple priorities and deadlines.
  • Advanced degree (PhD, MSc, or equivalent) in health economics, public health, health policy, statistics, or a related field.
  • At least 10 years of experience in health economics and outcomes research, with a strong background in oncology.
  • Demonstrated ability to lead cross-functional initiatives and influence senior stakeholders.
  • Proven experience in global health economics and outcomes research strategy, health technology assessment submissions, and payer engagement.
  • Strong expertise in health economic modeling, real-world evidence, and comparative effectiveness research.
  • Demonstrated expertise in indirect treatment comparisons, real-world evidence generation, and observational study designs such as registries.
  • Strong understanding of United States and European Union healthcare systems, reimbursement pathways, and payer requirements.
  • Ability to translate complex data into actionable insights.

Responsibilities

  • Execute integrated global health economics and outcomes research strategies across pipeline and marketed oncology products, aligning with regulatory, market access, and reimbursement requirements across key geographies.
  • Contribute to and drive end-to-end evidence-generation plans across the product lifecycle, integrating clinical, economic, and real-world evidence to support value demonstration and access.
  • Execute and oversee development of ex-United States value dossiers, aligning clinical, economic, and epidemiologic evidence with payer and health technology assessment requirements.
  • Oversee design and execution of real-world and observational studies, including retrospective studies, prospective cohorts, and registries, to generate evidence on effectiveness, safety, treatment patterns, and healthcare resource utilization.
  • Lead development and adaptation of cost-effectiveness and budget-impact models, aligning them with global and local market access strategies and payer expectations.
  • Lead design and execution of indirect treatment comparisons, external control arm studies, and other comparative effectiveness approaches, ensuring methodological rigor and alignment with health technology assessment expectations.
  • Oversee development of systematic literature reviews and evidence syntheses to support health technology assessment submissions, modeling inputs, and broader evidence strategies.
  • Provide strategic input into health technology assessment submissions and payer engagement, ensuring evidence packages address key uncertainties and support favorable reimbursement outcomes in global markets.
  • Advance methodological approaches in health economics, epidemiology, and outcomes research, including novel frameworks to support value demonstration.
  • Identify and leverage appropriate real-world data sources, including electronic health records, claims, and registries, and establish external partnerships to support timely and high-quality evidence generation.
  • Develop and deliver clear, data-driven insights to internal leadership and external stakeholders, supporting alignment on the value proposition of oncology therapies.
  • Lead cross-functional and cross-regional teams, fostering collaboration and driving high-quality, timely execution.
  • Uphold company principles by driving collaboration, embracing possibility, following data, and leading by doing, while aligning initiatives with the company’s ethics and patient-first mission.

Desired Qualifications

  • A focus on oncology is highly desirable.
  • Strong communication and presentation skills.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs